New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- Exploring why comprehensive care can make a big difference in cancer treatmenton November 30, 2019 at 9:06 pm
We believe there are eight core features that distinguish outstanding cancer care, and which can help guide families looking to select the best providers for their particular needs and circumstances.
- Outlook on the World's Skin Cancer Diagnostics and Therapeutics Market, 2019-2024: Growth, Trends & Projections - ResearchAndMarkets.comon November 29, 2019 at 6:15 am
DUBLIN--(BUSINESS WIRE)--The "Skin Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The global skin ...
- Chef with zest for life rebounds after cancer diagnosis. He’s thankful for the friends that rallied around him.on November 28, 2019 at 8:00 am
... borrowed time,” he said in a phone call from Hawaii where he and his wife Kathryne Cramer went to celebrate his cancer being in remission, or “reduced,” after receiving four chemo treatments since ...
- Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/mlon November 28, 2019 at 5:26 am
The aim of the study was to prospectively evaluate diagnostic performance of 18F-PSMA-1007 PET/CT in patients with prostate cancer (PCa) after radical treatment and low but rising prostate-specific ...
- Pancreatic cancer survivor says diagnosis doesn't have to be a death sentence, but research is keyon November 28, 2019 at 2:03 am
Which is why November - pancreatic cancer awareness month - is important for those impacted by the disease. The diagnosis of celebrities like Alex Trabek, Supreme Court Justice Ruth Bader Ginsburg, ...
- Global Cancer Diagnostics Market by Type, Application & Region - Forecast to 2025 - ResearchAndMarkets.comon November 27, 2019 at 4:04 pm
The "Cancer Diagnostics Market Size, Outlook and Growth Opportunities, 2019-2025" report has been added to ResearchAndMarkets.com's offering. This report includes the latest predictions of the global ...
- MRI Ups Early Breast Cancer Diagnosis in Women with Dense Breastson November 27, 2019 at 2:23 pm
Having dense breasts is a double-edged sword when it comes to screening for breast cancer: dense breast tissue may increase the risk for breast ... "We found that supplemental screening with MRI in ...
- 'I prayed a lot': Megadeth's Dave Mustaine details cancer diagnosis in new interviewon November 27, 2019 at 4:59 am
In his first interview since being diagnosed with cancer earlier this year, thrash metal icon Dave Mustaine says he turned to his family, faith and the “people around the globe praying for me” during ...
- Embrace Iowa fund helps single mom with cancer diagnosison November 26, 2019 at 1:10 pm
Embrace Iowa fund helps single mom with cancer diagnosis Learn how you can donate to Embrace Iowa to help other families in need. Check out this story on desmoinesregister.com: ...
via Bing News